Inverse targeting of reticuloendothelial system-rich organs after intravenous administration of adriamycin-loaded neutral proliposomes containing poloxamer 407 to rats

International Journal of Pharmaceutics

Volumn 131, Issue 1, 1996, Pages 91-96

  Lee, Hee J ^a   Ahn, Byung N ^a   Paik, Woo H ^b   Shim, Chang K ^a   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Boryung Pharm Co Ltd   (South Korea)

Author keywords

Adriamycin; Adriamycinol; Inverse targeting of RES; Pharmacokinetics; Poloxamer; Proliposomes

Indexed keywords

DOXORUBICIN; DOXORUBICINOL; LIPOSOME; POLOXAMER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TARGETING; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RAT; RETICULOENDOTHELIAL SYSTEM;

EID: 0029971752     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04234-2     Document Type: Article

References (22)

1. Balis, F.M., Pharmacokinetic drug interactions of commonly used anticancer drugs. Clin. Pharmacokinet., 11 (1986) 223-235.
2. Boston, R.C. and Phillips, D.R., Evidence of possible dose-dependent doxorubicin plasma kinetics in man. Cancer Treat. Rep., 67 (1983) 63-69.
3. Chiou, W.L., Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokinet. Biopharm., 6 (1978) 539-546.
4. Chiou, W.L., New calculation method for mean apparent drug volume of distribution and application to rationale dosage regimens. J. Pharm. Sci., 68 (1979) 1067-1069.
5. Frøkjaer, S., Hjorth, E. L. and Wørts, O., Stability testing of liposomes during storage. Liposome Technology, G. Gregoriadis Eds., CRC press Inc., Boca Raton, Florida, Vol. 1, 1984, pp. 235-245.
6. Gabizon, A.A., Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res., 52 (1992) 891-896.
7. Gewirtz, D.A. and Yanovich, S., Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit. Biochem. Pharmacol., 36 (1987) 1793-1798.
8. Gibaldi, M. and Perrier, D., Pharmacokinetics, 2nd Ed. Marcel-Dekker, New York, 1982.
9. Illum, L. and Davis, S.S., The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (poloxamer 338). FEBS Lett., 167 (1984) 79-92.
10. Illum, L., Davis, S.S., Müller, R.H., Mak, E. and West, P., The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer-poloxamine 908. Life Sci., 40 (1987) 367-374.
11. Katare, O.P., Vyas, S.P. and Dixit, V.K., Proliposomes of indomethacin for oral administration. J. Microencap., 8 (1991a) 1-7.
12. Katare, O.P., Vyas, S.P. and Dixit, V.K., Preparation and performance evaluation of plain proliposomal systems for cytoprotections. J. Microencap., 8 (1991b) 295-300.
13. Kirn, S.H., Choi, Y.M. and Lee, M.G., Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J. Pharmacokinet. Biopharm., 21 (1993) 1-17.
14. Lee, H.J., Ahn, B.N., Yoon, E.J., Paik, W.H., Shim C.K. and Lee, M.G., Pharmacokinetics and tissue distribution of adriamycin and adriamycinol after intravenous administration of adriamycin-loaded neutral proliposomes to rats. Int. J. Pharm., 121 (1995a) 1-10.
15. Lee, H.-J. and Chiou, W.L., Erythrocytes as barriers for drug elimination in the isolated rat liver. I. Doxorubicin. Pharm. Res., 6 (1989) 833-839.
16. Lee, M.J., Lee, M.H. and Shim, C.-K., Inverse targeting of drugs to reticuloendothelial system-rich organs by lipid microemulsion emulsified with poloxamer 338, Int. J. Pharm., 113 (1995b) 175-187.
17. Mayer, L.D. and Tai, L.C.L., Influence of vesicle size, lipid composition and drug-to- lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res., 49 (1989) 5922-5930.
18. Park, J.M., Ahn, B.-N., Yoon, E.J., Lee, M.G., Shim, C.-K. and Kim, C.-K., Pharmacokinetics of methotrexate after intravenous administration of methotrexate-loaded proliposomes to rats. Biopharm. Drug Disposit., 15 (1994) 391-407.
19. Payne, N.I., Browning, I. and Hynes, C.A., Characterization of proliposome. J. Pharm. Sci., 75 (1986a) 330-333.
20. Payne, N.I., Timmis, P., Ambrose, C.V., Warel, M.D. and Ridgway, F., Proliposomes: A novel solution to an old problem. J. Pharm. Sci., 75 (1986b) 325-329.
21. Powis, G., Ames, M.M. and Kovach, J.S., Dose-dependent pharmacokinetics and cancer chemotherapy. Cancer Chemother. Pharmacol., 6 (1981) 1-9.
22. van Hoesel, Q.G.C.M., Steerenberg, P.A., Crommelin, D.J.A. and van Dijk, A., Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat. Cancer Res., 44 (1984) 3698-3705.